title: Metabotropic transmitter actions in auditory thalamus.
abstract: Neurons in the ventral partition of the medial geniculate body (MGBv), the primary auditory thalamus, receive afferent input from the inferior colliculus via excitatory glutamate-ergic and inhibitory GABA-ergic input fibres. The feedback from the auditory cortex to the thalamic relay also is mediated via neuron systems using glutamate and GABA as transmitters. We studied effects on excitability mediated by these transmitters via G-protein coupled metabotropic receptors. In a slice preparation of rat thalamus we investigated the membrane responses of MGBv neurons using the whole cell recording technique. Application of a metabotropic glutamate receptor (mGluR) agonist, ACPD (5-100 microM), depolarized MGBv neurons. As a result, the burst mode of firing, which characterizes states of sleep at hyperpolarized potentials was replaced by the tonic mode, which is compatible with sound signal transmission during alertness. The depolarization was caused by an inward current (I(ACPD)) that persisted during blockade of Na+ channels with tetrodotoxin (TTX) and of Ca2+ channels with Cd2+. The I(ACPD) depended, however, on extracellular Na+, which could be replaced with Li+, excluding a major contribution of the Na+/Ca2+ exchange current. ACPD application also inhibited an inwardly rectifying K+ current at hyperpolarized potentials and activated an outward current in the depolarized range. Application of the GABA(B) agonist, baclofen (10 microM), hyperpolarized MGBv neurons by activation of an inwardly rectifying K+ current. The corresponding membrane conductance acted as a powerful shunt that reduced voltage responses and inhibited firing in both the tonic and burst modes. Thus, the effects of GABA(B) receptor activation would suppress auditory signal transfer, whereas mGluR activation enhances excitability, possibly accounting for the alerting effects of certain auditory stimuli.
authors.affiliation: Rotary Hearing Center, Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.
authors.forename: D W
authors.initials: DW
authors.lastname: Schwarz
authors.forename: F
authors.initials: F
authors.lastname: Tennigkeit
authors.forename: E
authors.initials: E
authors.lastname: Puil
mesh_terms: D000818:Animals; D001306:Auditory Pathways / Q000502:physiology*; D046508:Culture Techniques; D005829:Geniculate Bodies / Q000502:physiology*; D018698:Glutamic Acid / Q000502:physiology; D007245:Inferior Colliculi / Q000502:physiology*; D008564:Membrane Potentials / Q000502:physiology; D009474:Neurons / Q000502:physiology; D015221:Potassium Channels / Q000502:physiology; D051381:Rats; D018080:Receptors, GABA-B / Q000502:physiology; D018094:Receptors, Metabotropic Glutamate / Q000502:physiology*; D009435:Synaptic Transmission / Q000502:physiology*
chemical_list: D015221:Potassium Channels; D018080:Receptors, GABA-B; D018094:Receptors, Metabotropic Glutamate; D018698:Glutamic Acid